Hydroxychloroquine is available as the brand-name drug Plaquenil. Generic drugs usually cost less than the brand-name version. Hydroxychloroquine may be used as part of a combination therapy. Chloroquine phosphate fish Malaria resistant to chloroquine Indian Journal of Rheumatology 2008 September Original Article Volume 3, Number 3; pp. 93–97 Methotrexate and hydroxychloroquine combination therapy in chronic chikungunya arthritis a 16 week study S Pandya ABSTRACT Objective To study the clinical profile of patients of chronic chikungunya arthritis presenting to a rheumatology OPD in the Western part of India and to judge the treatment. Chinese found an In Vitro activity of Plaquenil, and maybe in Vivo too but the live study is not yet published. A Professor in France got interested in doing a trial in Marseille hospital, and was agreed a few days ago to do so Pr Raoult; He is studying Plaquenil use in viral and intracellular. Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis a 24-week randomized controlled open label study. Ravindran V12, Alias G3. Author information 1Department of Rheumatology, PVS Hospital, Calicut, India. [email protected] Hydroxychloroquine is used to treat lupus erythematosus and rheumatoid arthritis. It isn’t fully understood how this drug works to treat lupus erythematosus or rheumatoid arthritis. That means you may need to take it with other drugs. It treats malaria by killing the parasites that cause the disease. Hydroxychloroquine in chikungunya Chikungunya virus CDC, Hydroxychloroquine / Plaquenil and the Covid-19 / Coronavirus Phoenix. Hydro plaquenil Plaquenil is the brand name for the prescription drug hydroxychloroquine. It's used to treat and prevent malaria infection, and to reduce symptoms and progression of autoimmune diseases such as lupus, rheumatoid arthritis, and others. Plaquenil Hydroxychloroquine - Side Effects, Dosage, Interactions - Drugs. Efficacy of combination DMARD therapy vs. hydroxychloroquine.. Comparative evaluation of four therapeutic regimes in chikungunya.. Mar 03, 2017 The study was not designed to address treatment, but data from previous studies suggest that combination disease-modifying antirheumatic drug therapy may be more effective than hydroxychloroquine monotherapy for chronic joint pain post Chikungunya, the researchers noted. The researchers had no financial conflicts to disclose. Hydroxychloroquine is a disease-modifying anti-rheumatic drug DMARD. It regulates the activity of the immune system, which may be overactive in some conditions. Hydroxychloroquine can modify the underlying disease process, rather than simply treating the symptoms. Chikungunya can be a mild and self-limiting disease, but can also involve a complex spectrum of atypical, severe and/or chronic rheumatic manifestations that place a considerable burden on.